Clinical Trial Update: Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of fluvastatin in children with heterozygous familial hypercholesterolemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• Fluvastatin (fluvastatin)

Snippet

Sponsor: Novartis | Conditions: Heterozygous Familial Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | Status: COMPLETED